EMvision Medical Devices

EMvision Medical Devices EBIT Margin

The EBIT Margin (Operating Margin) of EMvision Medical Devices (EMV.AX) as of Oct 18, 2026 is -160.91 %. In the previous year, EBIT Margin (Operating Margin) was -14.39 % — a change of 1,018.25% (lower).

EBIT Margin

-160.91 %

YoY

1,018.25%

Last updated:

EBIT Margin (Operating Margin) of EMvision Medical Devices is 2025 -160.91 % . EBIT Margin (Operating Margin) of EMvision Medical Devices was 2024 -14.39 % . It decreases by 1,018.25% lower compared to the previous year.

For EMvision Medical Devices, the operating (EBIT) margin of -160.9% is up versus -599.5% a few years ago.

The EMvision Medical Devices EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
-271.43 AUD
Jan 1, 2019
-260.60 AUD
Jan 1, 2020
-354.35 AUD
Jan 1, 2021
-599.48 AUD
Jan 1, 2022
-185.34 AUD
Jan 1, 2023
-156.72 AUD
Jan 1, 2024
-14.39 AUD
Jan 1, 2025
-160.91 AUD
The EMvision Medical Devices EBIT Margin history
YEAREBIT MarginYoY
-160.91 %+1,018.25%
-14.39 %-90.82%
-156.72 %-15.44%
-185.34 %-69.08%
-599.48 %+69.18%
-354.35 %+35.97%
-260.60 %-3.99%
-271.43 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

EMvision Medical Devices Stock analysis

What does EMvision Medical Devices do? EMvision Medical Devices Ltd is a Sydney-based company listed in December 2018 that develops and commercializes medical imaging technology. Headquartered in New South Wales, the firm focuses on the research and development of diagnostic tools, specifically its EMVision Technology. The company aims to commercialize portable medical devices for stroke diagnosis and monitoring, as well as addressing other medical imaging requirements. Its product pipeline features portable, non-invasive neuroimaging devices designed for various disease states and emergencies. The lead development project is a portable, non-ionizing brain scanner that produces images of biological tissue to assist clinicians. Additionally, the company is working on a second-generation ultra-lightweight device intended for embedding in standard road and air ambulances to deliver pre-hospital stroke care regardless of location. EMvision Medical Devices is one of the most popular companies on Eulerpool.

Frequently Asked Questions about EMvision Medical Devices stock

EBIT Margin (Operating Margin) of EMvision Medical Devices is -160.91 % in 2025.

EBIT Margin (Operating Margin) of EMvision Medical Devices changed from -14.39 % to -160.91 %, representing a 1,018.25% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) EMvision Medical Devices since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s EMvision Medical Devices with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — EMvision Medical Devices

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — EMvision Medical Devices